MHC class II auto-antigen presentation is unconventional

被引:26
|
作者
Sadegh-Nasseri, Scheherazade [1 ]
Kim, AeRyon [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA
来源
FRONTIERS IN IMMUNOLOGY | 2015年 / 6卷
关键词
auto-antigens; immunodominance; HLA-DR antigens; cathepsin sensitivity; extracellular processing; paralyzed DC; cell free antigen-processing system; LYSOSOMAL CYSTEINE PROTEASES; DIABETOGENIC T-CELLS; CATHEPSIN-S; HLA-DM; ANTIGEN PRESENTATION; MOUSE MODEL; PEPTIDE; INSULIN; MOLECULES; SELECTION;
D O I
10.3389/fimmu.2015.00372
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigen presentation is highly critical in adoptive immunity. Only by interacting with antigens presented by major histocompatibility complex class II molecules, helper T cells can be stimulated to fight infections or diseases. The degradation of a full protein into small peptide fragments bound to class II molecules is a dynamic, lengthy process consisting of many steps and chaperons. Deregulation in any step of antigen processing could lead to the development of self-reactive T cells or defective immune response to pathogens. Indeed, human leukocyte antigens class II genes are the predominant contributors to susceptibility to autoimmune diseases. Conventional antigen-processing calls for internalization of extracellular antigens followed by processing and epitope selection within antigen-processing subcellular compartments, enriched with all necessary accessory molecules, processing enzymes, and proper pH and denaturing conditions. However, recent data examining the temporal relationship between antigen uptakes, processing, and epitope selection revealed unexpected characteristics for auto-antigenic epitopes, which were not shared with antigenic epitopes from pathogens. This review provides a discussion of the relevance of these findings to the mechanisms of autoimmunity.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [31] Protein degradation in MHC class II antigen presentation: opportunities for immunomodulation
    Medd, PG
    Chain, BM
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2000, 11 (03) : 203 - 210
  • [32] AUTO-ANTIGEN PRESENTATION BY MACROPHAGES IN EXPERIMENTAL AUTOIMMUNE-THYROIDITIS (EAT)
    MCGREGOR, AM
    WEETMAN, AP
    ANNALES D ENDOCRINOLOGIE, 1983, 44 (04) : A79 - A79
  • [33] HLA-DM and the MHC class II antigen presentation pathway
    Jensen, PE
    Weber, DA
    Thayer, WP
    Chen, XJ
    Dao, CT
    IMMUNOLOGIC RESEARCH, 1999, 20 (03) : 195 - 205
  • [34] THE BIOCHEMISTRY AND CELL BIOLOGY OF MHC CLASS-II ANTIGEN PRESENTATION
    GERMAIN, RN
    CASTELLINO, F
    RINKER, AG
    SADEGHNASSERI, S
    ROMAGNOLI, P
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 286 - 286
  • [35] An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation
    Bénédicte Manoury
    Eric W. Hewitt
    Nick Morrice
    Pam M. Dando
    Alan J. Barrett
    Colin Watts
    Nature, 1998, 396 : 695 - 699
  • [36] MHC class II-mediated antigen presentation by melanoma cells
    Brady, MS
    Eckels, DD
    Ree, SY
    Schultheiss, KE
    Lee, JS
    JOURNAL OF IMMUNOTHERAPY, 1996, 19 (06): : 387 - 397
  • [37] CELLULAR STUDIES ON ANTIGEN PRESENTATION BY CLASS-II MHC MOLECULES
    UNANUE, ER
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (01) : 63 - 69
  • [38] MHC class II expression and antigen presentation by human endometrial cells
    Wallace, PK
    Yeaman, GR
    Johnson, K
    Collins, JE
    Guyre, PM
    Wira, CR
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 76 (1-5): : 203 - 211
  • [39] Proteolysis in MHC class II antigen presentation: Who's in charge?
    Villadangos, JA
    Ploegh, HL
    IMMUNITY, 2000, 12 (03) : 233 - 239
  • [40] ANTIGEN PRESENTATION - GETTING PEPTIDES INTO MHC CLASS-II MOLECULES
    CRESSWELL, P
    CURRENT BIOLOGY, 1994, 4 (06) : 541 - 543